AUSTIN, Texas, April 23, 2025 /PRNewswire/ -- Vooglam, an innovative and culturally inspired eyewear brand known for its boundary-pushing frame designs, has recently unveiled a comprehensive rebrand that repositions the brand at the intersection of today's hottest style tribes and mainstream style. At the core of this rebrand is the launch of seven distinct product lines and a brand new ambassador program, "The Style Underground."
The new Vooglam aims to position eyewear as the ultimate accessory for personal expression, offering a curated pool of frames inspired by iconic cultural moments and movements. Using a two-pronged approach, the brand translates radical and expressive style tribes from Ravers to Afropunks into masterfully curated collections while inviting members of these subcultures to join Vooglam's global community in The Style Underground.
Each product line from Retro Radio and Pan Africa to Cyberpunk and Rave Culture transposes faithfully authentic motifs, details, and vocabulary into eyewear that allow wearers to "Show off their vision" no matter how loud or subdued. Each line interprets and subverts tropes and themes associated with a distinct subculture to ensure both accuracy and innovation are at the forefront of every product.
Meanwhile, The Style Underground, an exclusive ambassador program, connects influential insiders immersed in the latest creative currents with each other and with the brand based around a shared passion for true expression. The program demonstrates Vooglam's dedication to authenticity and representation while offering ambassadors early access to products, exclusive events, and co-design opportunities, bucking the unwelcome tendency of brands to exploit creative communities without credit. This further reflects the brand's vision of cultivating a global community by translating subcultural authenticity into personal style.
Meeting aesthetic needs may be a top priority; however, beyond aesthetics, Vooglam has ensured every frame is crafted with cutting-edge materials and techniques. The brand's premium prescription lenses and functional eyewear including UV protection, blue light filtering, and specialized driving glasses show that while style may be the brand's virtue par excellence, functionality has not been thrown to the wayside.
The rebrand is live now across all Vooglam platforms including web, mobile, and app. New styles and collections drop monthly. Fashion enthusiasts, subculture devotees, and eyewear collectors are invited to explore the collections and join Vooglam's mission to redefine eyewear as the ultimate accessory for fearless self-expression.
For more information about Vooglam and The Style Underground ambassador program, visit https://www.vooglam.com/ or follow @Vooglam on social media platforms.
About Vooglam
Established in 2017, Vooglam creates high-quality eyewear inspired by today's style tribes, transforming the functional into tools for self-expression. With a catalog of almost 2,000 unique frame designs available in over 170 countries, serving more than one million customers, Vooglam delivers eyewear for every look and need. The brand combines functional vision solutions with meticulously researched and authentic subcultural design elements, offering fully customizable eyewear that includes prescription lenses and lens types. Organized into seven distinctive product lines, Vooglam's offerings range from the audacious to the subtly creative. Through cutting-edge manufacturing techniques, premium materials, and rigorous quality control, Vooglam continues to transform how consumers express themselves through eyewear.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Vooglam Unveils Bold Rebrand, Launches Ambassador Program
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
